JP2022530890A5 - - Google Patents
Info
- Publication number
- JP2022530890A5 JP2022530890A5 JP2021564189A JP2021564189A JP2022530890A5 JP 2022530890 A5 JP2022530890 A5 JP 2022530890A5 JP 2021564189 A JP2021564189 A JP 2021564189A JP 2021564189 A JP2021564189 A JP 2021564189A JP 2022530890 A5 JP2022530890 A5 JP 2022530890A5
- Authority
- JP
- Japan
- Prior art keywords
- days
- body weight
- approximately
- cough
- alkylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2019085180 | 2019-04-30 | ||
| CNPCT/CN2019/085180 | 2019-04-30 | ||
| PCT/CN2020/087686 WO2020221274A1 (zh) | 2019-04-30 | 2020-04-29 | 二氨基嘧啶类化合物治疗咳嗽的方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022530890A JP2022530890A (ja) | 2022-07-04 |
| JP2022530890A5 true JP2022530890A5 (enExample) | 2023-05-11 |
| JP7665529B2 JP7665529B2 (ja) | 2025-04-21 |
Family
ID=73029672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021564189A Active JP7665529B2 (ja) | 2019-04-30 | 2020-04-29 | ジアミノピリミジン化合物を使用することによって咳を治療する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220211703A1 (enExample) |
| EP (1) | EP3960179B1 (enExample) |
| JP (1) | JP7665529B2 (enExample) |
| KR (1) | KR102935436B1 (enExample) |
| CN (1) | CN114007619B (enExample) |
| AU (1) | AU2020265327B2 (enExample) |
| BR (1) | BR112021021600A2 (enExample) |
| MX (1) | MX2021013338A (enExample) |
| SG (1) | SG11202111877TA (enExample) |
| TW (1) | TWI736243B (enExample) |
| WO (1) | WO2020221274A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117186068A (zh) * | 2017-11-01 | 2023-12-08 | 北京泰德制药股份有限公司 | P2x3和/或p2x2/3受体拮抗剂、包含其的药物组合物及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2557372C (en) * | 2004-03-05 | 2013-01-08 | F. Hoffmann-La Roche Ag | Diaminopyrimidines as p2x3 and p2x2/3 antagonists |
| EP1924564B1 (en) * | 2005-09-01 | 2016-11-09 | F.Hoffmann-La Roche Ag | Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| AU2007304280B2 (en) | 2006-10-04 | 2013-01-31 | F. Hoffmann-La Roche Ag | Process for synthesis of phenoxy diaminopyrimidine derivatives |
| AU2014308606B2 (en) * | 2013-08-23 | 2017-08-03 | Afferent Pharmaceuticals Inc. | Diaminopyrimidine P2X3 and P2X 2/3 receptor modulators for treatment of acute, sub-acute or chronic cough |
| DK3355889T3 (da) * | 2015-09-29 | 2023-05-15 | Afferent Pharmaceuticals Inc | Diaminopyrimidin-p2x3- og p2x2/3-receptormodulatorer til anvendelse i behandling af hoste |
| WO2017160569A1 (en) * | 2016-03-14 | 2017-09-21 | Afferent Pharmaceuticals Inc. | Pyrimidines and variants thereof, and uses therefor |
| AU2017237929B2 (en) * | 2016-03-25 | 2021-04-15 | Afferent Pharmaceuticals Inc. | Pyrimidines and variants thereof, and uses therefor |
| CN117186068A (zh) * | 2017-11-01 | 2023-12-08 | 北京泰德制药股份有限公司 | P2x3和/或p2x2/3受体拮抗剂、包含其的药物组合物及其用途 |
-
2020
- 2020-04-29 BR BR112021021600A patent/BR112021021600A2/pt unknown
- 2020-04-29 EP EP20799419.5A patent/EP3960179B1/en active Active
- 2020-04-29 JP JP2021564189A patent/JP7665529B2/ja active Active
- 2020-04-29 CN CN202080032489.4A patent/CN114007619B/zh active Active
- 2020-04-29 KR KR1020217038551A patent/KR102935436B1/ko active Active
- 2020-04-29 MX MX2021013338A patent/MX2021013338A/es unknown
- 2020-04-29 WO PCT/CN2020/087686 patent/WO2020221274A1/zh not_active Ceased
- 2020-04-29 US US17/607,438 patent/US20220211703A1/en active Pending
- 2020-04-29 SG SG11202111877TA patent/SG11202111877TA/en unknown
- 2020-04-29 AU AU2020265327A patent/AU2020265327B2/en active Active
- 2020-04-30 TW TW109114696A patent/TWI736243B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022522486A5 (enExample) | ||
| JP2022539329A5 (enExample) | ||
| TWI717026B (zh) | 使用齊墩果酸(bardoxolone methyl)或其類似物治療和預防內皮功能障礙之方法 | |
| ES2700542T3 (es) | Composición farmacéutica que comprende un derivado de pirazolo[1,5-A]pirimidina como un agente antiviral | |
| KR102309973B1 (ko) | 폐 병태의 치료를 위한 고침투 전구약물 조성물 및 그의 약제학적 조성물 | |
| US10682345B2 (en) | Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses | |
| AU2007220047B2 (en) | Inhibition of JAK2 as a treatment of pulmonary arterial hypertension | |
| JP2013519653A5 (enExample) | ||
| JP6218940B2 (ja) | キニン系化合物、その光学異性体及びその製造方法と医薬用途 | |
| JP2016526023A (ja) | Ｓｔａｔ６阻害剤 | |
| EP2080523A1 (en) | Compositions comprising an antimuscarinic and a long-acting beta-agonist | |
| US8541433B2 (en) | Combination comprising macitentan and paclitaxel for treating multi-drug resistant ovarian cancer | |
| JP2022530890A5 (enExample) | ||
| JP2007500676A (ja) | 抗コリン作用薬とベータ受容体刺激薬を含む吸入用薬剤 | |
| JP2022531570A5 (enExample) | ||
| TW202304914A (zh) | 經取代之四環羧酸、其類似物及使用其之方法 | |
| JP2023535035A5 (enExample) | ||
| JP2007524698A5 (enExample) | ||
| JP2007506784A (ja) | 双極性障害およびその他の認知障害の治療における、ケレリトリン、その類似体およびそれらの使用 | |
| JP2011501730A (ja) | 呼吸器系疾患を治療するためのニトロ誘導されたステロイドと気管支拡張剤との組合せ | |
| JP7665529B2 (ja) | ジアミノピリミジン化合物を使用することによって咳を治療する方法 | |
| US11197851B2 (en) | Methods of treatment of asthma and COPD | |
| CN120035442A (zh) | 治疗尘肺病的方法 | |
| HK40113783A (zh) | 用於治疗病毒感染的化合物和方法 | |
| WO2009104152A1 (en) | Combination treatment for ovarian cancer |